Jazz Pharmaceuticals
JAZZ
#2003
Rank
NZ$17.36 B
Marketcap
NZ$285.77
Share price
1.03%
Change (1 day)
30.04%
Change (1 year)

Market capitalization of Jazz Pharmaceuticals (JAZZ)

Market cap: NZ$17.36 Billion

As of January 2026 Jazz Pharmaceuticals has a market cap of NZ$17.36 Billion. This makes Jazz Pharmaceuticals the world's 2003th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jazz Pharmaceuticals from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.36 B-2.92%
2025NZ$17.88 B33.92%
2024NZ$13.35 B9.08%
2023NZ$12.24 B-22.5%
2022NZ$15.79 B37.8%
2021NZ$11.46 B-10.77%
2020NZ$12.84 B3.26%
2019NZ$12.44 B17.1%
2018NZ$10.62 B-6.51%
2017NZ$11.36 B20.57%
2016NZ$9.42 B-25.12%
2015NZ$12.59 B-0.65%
2014NZ$12.67 B42.23%
2013NZ$8.91 B137.27%
2012NZ$3.75 B79.97%
2011NZ$2.08 B104.71%
2010NZ$1.01 B200.6%
2009NZ$0.33 B315.3%
2008NZ$81.64 M-82.67%
2007NZ$0.47 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Jazz Pharmaceuticals was reported to be:

NZ$17.18 Billion
by Nasdaq info icon info icon
NZ$17.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Endo International
ENDPQ
NZ$0.24 M-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
NZ$62.95 B 262.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$483.52 B 2,684.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
NZ$64.85 B 273.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel